The notices it replaced
- Reissues: RFA-MH-17-614 Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01)
- 2 steps back: RFA-MH-16-425 Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01)
- 3 steps back: RFA-MH-15-340 Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01)
Replaced by PAR-21-132.
Who won it before
22 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $19,330,193 in first-year total cost, median $776,277.
Most frequent study sections
- Special Emphasis Panel[ZMH1 ERB-D (04)]5
- Special Emphasis Panel[ZMH1 ERB-B (04)]3
- Special Emphasis Panel[ZMH1 ERB-D (03)]3
- Special Emphasis Panel[ZMH1 ERB-B (02)]2
- Special Emphasis Panel[ZMH1 ERB-B (07)]2
Most frequent institutions
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH3
- STANFORD UNIVERSITY2
- UNIVERSITY OF CALIFORNIA LOS ANGELES2
- CENTRE FOR ADDICTION AND MENTAL HEALTH1
- COLUMBIA UNIVERSITY HEALTH SCIENCES1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Neuroplasticity-Based Computerized Cognitive Remediation (nCCR) for Treatment Resistant Late-Life Depression1R01MH126051-01 | MORIMOTO, SARAH SHIZUKOSTEFFENS, DAVID C. | UNIVERSITY OF UTAH, UT | $1,503,141 | ZMH1 |
| 2021 | Early Intervention for Youth At-Risk for Bipolar Disorder1R01MH125971-01 | GOLDSTEIN, TINA R | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $664,442 | ZMH1 |
| 2021 | A Wearable Morning Light Treatment for Postpartum Depression: Confirming Efficacy and Mechanisms1R01MH121531-01A1 | SWANSON, LESLIE M | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $560,929 | ZMH1 |
| 2021 | Efficacy of an integrated intervention to treat maternal depression and children’s behavior problems: A transactional perspective1R56MH127032-01 | ROUBINOV, DANIELLE S. | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $429,059 | ZMH1 |
| 2020 | Family-Focused Therapy for Individuals at High Clinical Risk for Psychosis: A Confirmatory Efficacy Trial1R01MH123575-01 | BEARDEN, CARRIE EMIKLOWITZ, DAVID JAY | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $1,477,527 | ZMH1 |
| 2020 | Personalized Integrated Chronotherapy for Perinatal Depression1R01MH118269-01A1 | SHARKEY, KATHERINE M | RHODE ISLAND HOSPITAL, RI | $1,377,132 | ZMH1 |
| 2020 | Confirming the Efficacy/Mechanism of Family Therapy for Children with Low Weight Avoidant/Restrictive Food Intake Disorder (ARFID)1R01MH121292-01A1 | LOCK, JAMES D | STANFORD UNIVERSITY, CA | $709,636 | ZMH1 |
| 2020 | Efficacy of Personalizing Cognitive Remediation for Schizophrenia by Targeting Impairments in Early Auditory Processing1R01MH123561-01 | MEDALIA, ALICE | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $496,849 | ZMH1 |
| 2020 | Suicide Prevention for Patients with Chronic Pain1R56MH121555-01 | MCANDREW, LISA MARIE | VETERANS BIOMEDICAL RESEARCH INSTITUTE, NJ | $336,791 | ZMH1 |
| 2019 | Efficacy of biomarker-guided rTMS for treatment resistant depression1R01MH118388-01 | GUNNING, FAITH MLISTON, CONOR MWILLIAMS, NOLAN R. | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $1,245,371 | ZMH1 |
| 2019 | Targeting Attention Orienting to Social Threat to Reduce Social Anxiety in Youth1R01MH119299-01 | PETTIT, JEREMY WSILVERMAN, WENDY K. | FLORIDA INTERNATIONAL UNIVERSITY, FL | $1,130,654 | ZMH1 |
| 2019 | Cognitive Enhancement for Persistent Negative Symptoms in Schizophrenia1R01MH118267-01A1 | EACK, SHAUN M | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $741,755 | ZMH1 |
| 2019 | Efficacy of a Healthy Lifestyle Intervention to Prevent Depression in Older Spousally-bereaved Adults1R01MH118270-01A1 | STAHL, SARAH T | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $445,778 | ZMH1 |
| 2018 | Investigating Social Competence in Youth with Autism: A Multisite RCT1R01MH114906-01 · under RFA-MH-17-614 | CORBETT, BLYTHE ANNE | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $784,741 | ZMH1 |
| 2018 | Optimizing Long-Term Outcomes for Winter Depression with CBT-SAD and Light Therapy: Confirming the Targets, Mechanisms, and Treatment Sequence1R01MH112819-01A1 · under RFA-MH-17-614 | ROHAN, KELLY J. | UNIVERSITY OF VERMONT & ST AGRIC COLLEGE, VT | $679,218 | ZMH1 |
| 2018 | Evaluating the Efficacy of Central Executive Training (CET) for ADHD1R01MH115048-01 · under RFA-MH-17-614 | KOFLER, MICHAEL J | FLORIDA STATE UNIVERSITY, FL | $382,500 | ZMH1 |
| 2017 | Improving Cognition via Exercise in Schizophrenia1R01MH110623-01A1 · under RFA-MH-16-425 | KIMHY, DAVIDSTROUP, THOMAS SCOTT | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $1,555,921 | ZMH1 |
| 2017 | Confirmatory Safety and Efficacy Trial of Magnetic Seizure Therapy for Depression1R01MH112815-01 · under RFA-MH-16-425 | DASKALAKIS, ZAFIRIS J. | CENTRE FOR ADDICTION AND MENTAL HEALTH, ON | $1,542,062 | ZMH1 |
| 2017 | Confirmatory Double-Blind Placebo-Controlled Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons with Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies1R01MH113617-01 · under RFA-MH-16-425 | EATON, WILLIAM WKELLY, DEANNA L | UNIVERSITY OF MARYLAND BALTIMORE, MD | $801,031 | ZMH1 |
| 2017 | Confirming the Efficacy/Mechanism of an Adaptive Treatment for Adolescent Anorexia Nervosa1R01MH110538-01A1 · under RFA-MH-16-425 | LOCK, JAMES D | STANFORD UNIVERSITY, CA | $794,125 | ZMH1 |
| 2016 | Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode1R01MH110544-01 · under RFA-MH-16-425 | NUECHTERLEIN, KEITH H | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $903,718 | ZMH1 |
| 2016 | Improving Depression Outcome by Enhancing Memory for Cognitive Therapy1R01MH108657-01A1 · under RFA-MH-16-425 | HARVEY, ALLISON G | UNIVERSITY OF CALIFORNIA BERKELEY, CA | $767,813 | ZMH1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.